Neogen makes diagnostic test kits and related products used to detect contaminants — pathogens, mycotoxins, allergens, and spoilage organisms — in food and animal feed. Customers include food producers, processors, grain elevators, meat and poultry plants, beverage companies, and regulatory agencies. Neogen's core value proposition is speed and accuracy: its tests produce rapid results that help customers avoid product recalls, regulatory action, and foodborne illness outbreaks. Neogen sells primarily consumable, single-use test kits that must be repurchased every time a customer runs a test, creating a recurring revenue stream. The company sells directly through a specialized food safety sales force and through distributors in over 100 countries, with direct offices in 28 countries outside the U.S. Food Safety generates roughly 71% of revenue and covers pathogen detection, natural toxins and allergens, culture media, and sanitation testing. The Animal Safety segment (~29% of revenue) sells veterinary instruments, animal health products, rodent and insect control, and genomics services. Neogen is in the process of divesting its Genomics business and has already sold its Cleaners and Disinfectants business, moves intended to focus the company on food safety and pay down the ~$900M in debt taken on to fund the 2022 acquisition of 3M's Food Safety Division. That acquisition roughly doubled Neogen's size but created ongoing integration challenges, particularly around sample collection production and the transition of Petrifilm manufacturing to Neogen's own facility in Lansing, Michigan.